I-CAS 204656-20-2 I-Liraglutide yase-China ukuthengiswa okuqondile kwefekthri okuhle kakhulu Ukuphepha Okuhlanzekile Okuphezulu ukuthunyelwa okuphezulu Ikhwalithi efanele amanani afanele ama-costomers aphezulu ukwaneliseka Ukulethwa Ngokushesha

I-Liraglutide iwuhlobo olusha lomuthi we-hypoglycemic owenza kusebenze i-protein kinase ecushwe yi-AMP ngaleyo ndlela ithuthukise ukuzwela kwe-insulin. Ayigcini nje ngokuba nomphumela obalulekile we-hypoglycemic, kodwa futhi inemisebenzi yokwehlisa isisindo, ukunciphisa umfutho wegazi, kanye nokwenza ngcono iphrofayili ye-lipid yegazi.

I-Liraglutide, i-glucagon-like peptide-1 (GLP-1) receptor agonist yomuntu, yehlisa ukuphuma kwesisu, yandisa ukusutha, futhi yehlisa ukudla kwesiguli, kuyilapho inciphisa isifiso sobuchopho sokudla futhi ivumela umzimba ukuba Ukwenyuswa kwezindleko zamandla kudlala indima esisindo. ukulahlekelwa; ivimbela isibindi ekukhiqizeni i-glucose eningi futhi ikhuthaza ama-pancreas ukuthi akhiqize i-insulin eyengeziwe ukuze ehlise ushukela wegazi; ngaphezu kwalokho, i-liraglutide nayo inezinzuzo zenhliziyo nokuvikelwa kwezinso.